These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
625 related items for PubMed ID: 14671148
1. Pegvisomant-induced serum insulin-like growth factor-I normalization in patients with acromegaly returns elevated markers of bone turnover to normal. Parkinson C, Kassem M, Heickendorff L, Flyvbjerg A, Trainer PJ. J Clin Endocrinol Metab; 2003 Dec; 88(12):5650-5. PubMed ID: 14671148 [Abstract] [Full Text] [Related]
2. Effects of a growth hormone receptor antagonist on bone markers in acromegaly. Fairfield WP, Sesmilo G, Katznelson L, Pulaski K, Freda PU, Stavrou S, Kleinberg D, Klibanski A. Clin Endocrinol (Oxf); 2002 Sep; 57(3):385-90. PubMed ID: 12201832 [Abstract] [Full Text] [Related]
7. Effects of short-term recombinant human insulin-like growth factor I administration on bone turnover in osteopenic women with anorexia nervosa. Grinspoon S, Baum H, Lee K, Anderson E, Herzog D, Klibanski A. J Clin Endocrinol Metab; 1996 Nov; 81(11):3864-70. PubMed ID: 8923830 [Abstract] [Full Text] [Related]
8. Elite volunteer athletes of different sport disciplines may have elevated baseline GH levels divorced from unaltered levels of both IGF-I and GH-dependent bone and collagen markers: a study on-the-field. Sartorio A, Marazzi N, Agosti F, Faglia G, Corradini C, De Palo E, Cella S, Rigamonti A, Muller EE. J Endocrinol Invest; 2004 May; 27(5):410-5. PubMed ID: 15279071 [Abstract] [Full Text] [Related]
9. Biochemical assessment of bone formation and resorption in acromegaly. Ezzat S, Melmed S, Endres D, Eyre DR, Singer FR. J Clin Endocrinol Metab; 1993 Jun; 76(6):1452-7. PubMed ID: 8501150 [Abstract] [Full Text] [Related]
13. Dose-dependent effects of recombinant human growth hormone on biochemical markers of bone and collagen metabolism in adult growth hormone deficiency. Bollerslev J, Møller J, Thomas S, Djøseland O, Christiansen JS. Eur J Endocrinol; 1996 Dec; 135(6):666-71. PubMed ID: 9025710 [Abstract] [Full Text] [Related]
14. Insulin-like growth factor system components in hyperparathyroidism and renal osteodystrophy. Jehle PM, Ostertag A, Schulten K, Schulz W, Jehle DR, Stracke S, Fiedler R, Deuber HJ, Keller F, Boehm BO, Baylink DJ, Mohan S. Kidney Int; 2000 Feb; 57(2):423-36. PubMed ID: 10652019 [Abstract] [Full Text] [Related]
15. Effects of intranasal 17beta-estradiol on bone turnover and serum insulin-like growth factor I in postmenopausal women. Garnero P, Tsouderos Y, Marton I, Pelissier C, Varin C, Delmas PD. J Clin Endocrinol Metab; 1999 Jul; 84(7):2390-7. PubMed ID: 10404809 [Abstract] [Full Text] [Related]
16. Insulin-like growth factor-1 is associated with bone formation markers, PTH and bone mineral density in healthy premenopausal women. Adami S, Zivelonghi A, Braga V, Fracassi E, Gatti D, Rossini M, Ulivieri FM, Viapiana O. Bone; 2010 Jan; 46(1):244-7. PubMed ID: 19853071 [Abstract] [Full Text] [Related]
17. Quantitative ultrasound of the heel and some parameters of bone turnover in patients with acromegaly. Bolanowski M, Jedrzejuk D, Milewicz A, Arkowska A. Osteoporos Int; 2002 Jan; 13(4):303-8. PubMed ID: 12030545 [Abstract] [Full Text] [Related]
18. Calcium and Bone Turnover Markers in Acromegaly: A Prospective, Controlled Study. Constantin T, Tangpricha V, Shah R, Oyesiku NM, Ioachimescu OC, Ritchie J, Ioachimescu AG. J Clin Endocrinol Metab; 2017 Jul 01; 102(7):2416-2424. PubMed ID: 28407138 [Abstract] [Full Text] [Related]